Clinical Trials Sponsored by ImmunityBio, Inc.
Total 35358 results
-
ImmunityBio, Inc.Not yet recruitingNon-Hodgkin Lymphoma Refractory/ Relapsed
-
ImmunityBio, Inc.Not yet recruitingHPV-Related Carcinoma
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.WithdrawnLymphoma | Lymphoma, B-Cell | Diffuse Large B Cell Lymphoma | Large-cell LymphomaUnited States
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
ImmunityBio, Inc.CompletedMalignant Solid TumourUnited States
-
ImmunityBio, Inc.CompletedKaposi's Sarcoma | AIDS | HIV PositiveUnited States
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.UnknownSquamous Cell CarcinomaUnited States
-
ImmunityBio, Inc.Unknown
-
ImmunityBio, Inc.CompletedSolid TumorUnited States
-
ImmunityBio, Inc.Not yet recruiting
-
ImmunityBio, Inc.Not yet recruitingNon Hodgkin's Lymphoma Refractory/RelapsedUnited States
-
ImmunityBio, Inc.RecruitingQUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid TumorsMetastatic Solid TumorUnited States
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.CompletedMetastatic, Locally Advanced or Unresectable Soft Tissue SarcomaUnited States, Spain, Denmark, Israel, Canada, Australia, Hungary, Chile, France, Italy, Netherlands, Poland, Russian Federation
-
ImmunityBio, Inc.CompletedMetastatic Solid TumorsUnited States
-
ImmunityBio, Inc.Completed
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.Unknown
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.WithdrawnHepatocellular Carcinoma Non-resectable | Hepatocellular Carcinoma RecurrentUnited States
-
ImmunityBio, Inc.Withdrawn
-
ImmunityBio, Inc.Unknown
-
ImmunityBio, Inc.UnknownPancreatic CancerUnited States
-
ImmunityBio, Inc.Recruiting
-
ImmunityBio, Inc.Recruiting
-
ImmunityBio, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Locally Advanced Solid TumorUnited States
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
ImmunityBio, Inc.CompletedCOVID-19United States
-
ImmunityBio, Inc.Active, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability | Mismatch Repair DeficiencyUnited States
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.TerminatedMerkel Cell CarcinomaUnited States
-
ImmunityBio, Inc.Completed
-
ImmunityBio, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
ImmunityBio, Inc.Active, not recruiting
-
ImmunityBio, Inc.CompletedMetastatic, Locally Advanced, or Unresectable Soft Tissue SarcomaUnited States
-
ImmunityBio, Inc.Completed
-
ImmunityBio, Inc.CompletedGlioblastomaUnited States